(Q39563381)

13 September 2017

title

15-hydroxyprostaglandin dehydrogenase is downregulated and exhibits tumor suppressor activity in gastric cancer (English)

1 reference

13 September 2017

Dong-Hoon Yang

10

0 references

Seung-Jae Myung

object named as

Seung-Jae Myung

2

0 references

Ho June Song

1

object named as

Ho June Song

1 reference

13 September 2017

11

Hwoon-Yong Jung

1 reference

13 September 2017

In-Wha Kim

3

1 reference

13 September 2017

Jin-Yong Jeong

4

1 reference

13 September 2017

Young Soo Park

5

1 reference

13 September 2017

Sun Mi Lee

6

1 reference

13 September 2017

Won Hee Nam

7

1 reference

13 September 2017

Yeon-Mi Ryu

8

1 reference

13 September 2017

Stephen P Fink

9

1 reference

13 September 2017

Jin-Ho Kim

12

1 reference

13 September 2017

publication date

1 May 2011

1 reference

13 September 2017

1 reference

13 September 2017

volume

29

1 reference

13 September 2017

issue

4

1 reference

13 September 2017

page(s)

257-265

1 reference

Prostaglandins and cancer

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.568562

Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.568562

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.568562

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.568562

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.568562

15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.568562

15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.568562

15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.568562

NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.568562

15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.568562

21 January 2018

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.568562

Cyclooxygenase-2 is an independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor HuR.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.568562

Expression of 15-PGDH is downregulated by COX-2 in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.568562

15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.568562

Carcinogenesis of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.568562

Repression of prostaglandin dehydrogenase by epidermal growth factor and snail increases prostaglandin E2 and promotes cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.568562

Inhibition of epidermal growth factor receptor signaling elevates 15-hydroxyprostaglandin dehydrogenase in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.568562

Aspirin and risk for gastric cancer: a population-based case-control study in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.568562

Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.568562

Genetic deletion of mPGES-1 suppresses intestinal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.568562

Regulation of prostaglandin transporters in colorectal neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.568562

15-Hydroxyprostaglandin dehydrogenase inactivation as a mechanism of resistance to celecoxib chemoprevention of colon tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.568562

Structure and function of human NAD(+)-linked 15-hydroxyprostaglandin dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.568562

15-Hydroxyprostaglandin dehydrogenase is a target of hepatocyte nuclear factor 3beta and a tumor suppressor in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.568562

10.3109/07357907.2011.568562

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference